The Nasdaq finally hit a new high, but is again extended. Several leaders offered new entries, including Taiwan Semiconductor. Investors need to be nimble, and patient.
Lilly's new weight-loss drug could top $62 billion in 2030 sales, an analyst said Friday as he boosted his price target on Eli Lilly stock to 1,000.
There's a growing field of competitors in the weight-loss drugs space, where Lilly and Novo currently dominate. Is Eli Lilly stock a buy?